Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expression. (25/51)

 (+info)

Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine. (26/51)

 (+info)

Identification of cystatin SA as a novel inhibitor of acid ceramidase. (27/51)

 (+info)

Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expression. (28/51)

 (+info)

Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. (29/51)

 (+info)

DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells. (30/51)

 (+info)

Novel biochemical abnormalities and genotype in Farber disease. (31/51)

Farber disease caused by acid ceramidase deficiency is characterised by a triad of painful and swollen joints, subcutaneous nodules, and laryngeal involvement. A one year old female with overlapping features of the classical and type 5 variants is reported. Sialuria and elevated plasma chitotriosidase were unusual findings. A novel mutation of the ASAH 1 gene was detected from DNA extracted from the umbilical stump.  (+info)

Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. (32/51)

 (+info)